• OPEN AN ACCOUNT
Indian Indices
Nifty
24,631.30 11.95
(0.05%)
Sensex
80,597.66 57.75
( 0.07%)
Bank Nifty
55,341.85 160.40
( 0.29%)
Nifty IT
34,833.20 140.25
( 0.40%)
Global Indices
Nasdaq
44,924.55 -18.73
(-0.04%)
Dow Jones
6,489.27 1.69
(0.03%)
Hang Seng
42,649.26 -625.41
(-1.45%)
Nikkei 225
9,177.24 12.01
(0.13%)
Forex
USD-INR
87.63 0.02
(0.02%)
EUR-INR
102.01 0.08
(0.08%)
GBP-INR
118.04 0.28
(0.24%)
JPY-INR
0.59 0.00
(-0.19%)

EQUITY - MARKET SCREENER

Spectrum Talent Management Ltd
Industry :  Diversified - Medium / Small
BSE Code
ISIN Demat
Book Value()
78655
INE0OL001018
68.1645701
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SPECTSTM
37.25
256.33
EPS(TTM)
Face Value()
Div & Yield %
2.98
10
0
 

Jenburkt Pharmaceuticals standalone net profit rises 8.38% in the March 2025 quarter
May 21,2025
Net profit of Jenburkt Pharmaceuticals rose 8.38% to Rs 8.54 crore in the quarter ended March 2025 as against Rs 7.88 crore during the previous quarter ended March 2024. Sales rose 5.69% to Rs 41.05 crore in the quarter ended March 2025 as against Rs 38.84 crore during the previous quarter ended March 2024.

For the full year,net profit rose 23.40% to Rs 32.06 crore in the year ended March 2025 as against Rs 25.98 crore during the previous year ended March 2024. Sales rose 6.85% to Rs 151.69 crore in the year ended March 2025 as against Rs 141.97 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales41.0538.84 6 151.69141.97 7
OPM %26.4625.36 -26.6323.33 -
PBDT12.6310.98 15 46.6637.52 24
PBT11.8410.36 14 43.9335.18 25
NP8.547.88 8 32.0625.98 23